DILT-CD Drug Patent Profile
✉ Email this page to a colleague
When do Dilt-cd patents expire, and when can generic versions of Dilt-cd launch?
Dilt-cd is a drug marketed by Apotex and is included in one NDA.
The generic ingredient in DILT-CD is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dilt-cd
A generic version of DILT-CD was approved as diltiazem hydrochloride by TEVA on May 31st, 1995.
Summary for DILT-CD
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 58 |
Patent Applications: | 4,206 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DILT-CD at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DILT-CD
US Patents and Regulatory Information for DILT-CD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apotex | DILT-CD | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 076151-001 | May 20, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apotex | DILT-CD | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 076151-004 | May 20, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apotex | DILT-CD | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 076151-002 | May 20, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apotex | DILT-CD | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 076151-003 | May 20, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |